Charles River Laboratories International, Inc. (CRL) is in Healthcare, Diagnostics & Research, based in United States, listed on NYSE. Market cap 14.23B USD. 52-week range 146.20 to 333.30 USD. Data as of 2026-10-09.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, ...